Protection of bone marrow cells from toxicity of chemotherapeutic agents targeted toward thymidylate synthase by transfer of mutant forms of human thymidylate synthase cDNA.
Banerjee
D
D
Program of Molecular Pharmacology and Experimental Therapeutics, Sloan Kettering Institute for Cancer Research, New York, N.Y., USA. banerjed@mskcc.org
Tong
Y
Y
Liu-Chen
X
X
Capiaux
G
G
Ercikan-Abali
E A
EA
Takebe
N
N
O'Connor
O A
OA
Bertino
J R
JR
D000970:Antineoplastic Agents / Q000009:adverse effects*; D001854:Bone Marrow Cells / Q000187:drug effects*; D018076:DNA, Complementary / Q000235:genetics*; D018014:Gene Transfer Techniques; D006801:Humans; D009154:Mutation; D013940:Thymidylate Synthase / Q000235:genetics*
D000970:Antineoplastic Agents; D018076:DNA, Complementary; D013940:Thymidylate Synthase